Program performance
What students demonstrated through program assessments across Years 1–3 and academic years.
What does the available evidence tell us about how well students are achieving the intended learning outcomes of this stream?
This workspace brings together what students demonstrate in program assessments, external licensure performance, and graduating-student self-report. These perspectives remain distinct so reviewers can understand what each contributes before considering the overall achievement picture.
What evidence am I reviewing?
What students demonstrated through program assessments across Years 1–3 and academic years.
PEBC MCQ and OSCE results provide an external perspective on achievement. The two components remain separate because they use different measures.
AFPC and CCAPP self-report evidence shows how graduating students describe preparedness and where they report developing knowledge and skills.
What do program assessments show about student performance in this stream?
After a slight fall from two academic years ago, year two's average moved substantially higher compared with the previous academic year.
In the selected academic year, year one has a much larger share of students in higher score ranges than in the previous academic year.
| PHARM 215 | Year 1 | 2025-2026 | 135 | 92.3% | 96.0% | 7.3% |
| PHARM 215 | Year 1 | 2024-2025 | 135 | 95.4% | 96.0% | 3.3% |
| PHARM 215 | Year 1 | 2023-2024 | 136 | 85.2% | 88.0% | 13.8% |
| PHARM 220 | Year 1 | 2024-2025 | 135 | 81.7% | 82.7% | 6.7% |
| PHARM 220 | Year 1 | 2023-2024 | 136 | 84.7% | 85.4% | 5.8% |
| PHARM 223 | Year 1 | 2024-2025 | 134 | 81.5% | 82.3% | 7.1% |
| PHARM 223 | Year 1 | 2023-2024 | 136 | 76.7% | 77.6% | 6.4% |
| PHARM 320 | Year 2 | 2025-2026 | 134 | 74.6% | 76.1% | 8.6% |
| PHARM 320 | Year 2 | 2024-2025 | 133 | 76.3% | 77.3% | 7.7% |
| PHARM 320 | Year 2 | 2023-2024 | 139 | 75.8% | 76.7% | 7.5% |
| PHARM 323 | Year 2 | 2025-2026 | 133 | 73.6% | 74.3% | 7.9% |
| PHARM 323 | Year 2 | 2024-2025 | 133 | 74.2% | 74.7% | 8.2% |
| PHARM 323 | Year 2 | 2023-2024 | 139 | 75.5% | 77.1% | 8.5% |
| PHARM 420 | Year 3 | 2025-2026 | 130 | 77.8% | 78.2% | 7.1% |
| PHARM 420 | Year 3 | 2024-2025 | 135 | 82.2% | 83.2% | 7.1% |
| PHARM 420 | Year 3 | 2023-2024 | 125 | 74.9% | 74.3% | 7.9% |
| PHARM 423 | Year 3 | 2025-2026 | 130 | 76.3% | 76.5% | 8.4% |
| PHARM 423 | Year 3 | 2024-2025 | 133 | 73.9% | 74.9% | 6.8% |
| PHARM 423 | Year 3 | 2023-2024 | 126 | 75.8% | 76.1% | 5.3% |
Calculation note. For each student, exam scores were averaged within each course. Those course averages were then averaged to summarize performance across the stream. Years 1, 2 and 3 are shown separately.
Average and median scores increased relative to the previous academic year, and the score profile shifted so more students fell into the higher score bands than before.
In the selected academic year, Year one has a larger concentration of students in the higher score bands, whereas Years two and three show greater proportions clustered in lower bands.
| PHARM 215 | Year 1 | 2025-2026 | 135 | 92.3% | 96.0% | 7.3% |
| PHARM 215 | Year 1 | 2024-2025 | 135 | 95.4% | 96.0% | 3.3% |
| PHARM 215 | Year 1 | 2023-2024 | 136 | 85.2% | 88.0% | 13.8% |
| PHARM 220 | Year 1 | 2024-2025 | 135 | 81.7% | 82.7% | 6.7% |
| PHARM 220 | Year 1 | 2023-2024 | 136 | 84.7% | 85.4% | 5.8% |
| PHARM 223 | Year 1 | 2024-2025 | 134 | 81.5% | 82.3% | 7.1% |
| PHARM 223 | Year 1 | 2023-2024 | 136 | 76.7% | 77.6% | 6.4% |
| PHARM 320 | Year 2 | 2025-2026 | 134 | 74.6% | 76.1% | 8.6% |
| PHARM 320 | Year 2 | 2024-2025 | 133 | 76.3% | 77.3% | 7.7% |
| PHARM 320 | Year 2 | 2023-2024 | 139 | 75.8% | 76.7% | 7.5% |
| PHARM 323 | Year 2 | 2025-2026 | 133 | 73.6% | 74.3% | 7.9% |
| PHARM 323 | Year 2 | 2024-2025 | 133 | 74.2% | 74.7% | 8.2% |
| PHARM 323 | Year 2 | 2023-2024 | 139 | 75.5% | 77.1% | 8.5% |
| PHARM 420 | Year 3 | 2025-2026 | 130 | 77.8% | 78.2% | 7.1% |
| PHARM 420 | Year 3 | 2024-2025 | 135 | 82.2% | 83.2% | 7.1% |
| PHARM 420 | Year 3 | 2023-2024 | 125 | 74.9% | 74.3% | 7.9% |
| PHARM 423 | Year 3 | 2025-2026 | 130 | 76.3% | 76.5% | 8.4% |
| PHARM 423 | Year 3 | 2024-2025 | 133 | 73.9% | 74.9% | 6.8% |
| PHARM 423 | Year 3 | 2023-2024 | 126 | 75.8% | 76.1% | 5.3% |
Calculation note. For each student, exam scores were averaged within each course. Those course averages were then averaged to summarize performance across the stream. Years 1, 2 and 3 are shown separately.
Course-level performance for Year one climbed substantially compared with the previous academic year and is higher than two academic years ago, reversing earlier dips.
In the selected academic year most Year one students cluster in the highest score band, shifting upward from the previous academic year where scores were mainly in the upper middle band.
| PHARM 215 | Year 1 | 2025-2026 | 135 | 92.3% | 96.0% | 7.3% |
| PHARM 215 | Year 1 | 2024-2025 | 135 | 95.4% | 96.0% | 3.3% |
| PHARM 215 | Year 1 | 2023-2024 | 136 | 85.2% | 88.0% | 13.8% |
| PHARM 220 | Year 1 | 2024-2025 | 135 | 81.7% | 82.7% | 6.7% |
| PHARM 220 | Year 1 | 2023-2024 | 136 | 84.7% | 85.4% | 5.8% |
| PHARM 223 | Year 1 | 2024-2025 | 134 | 81.5% | 82.3% | 7.1% |
| PHARM 223 | Year 1 | 2023-2024 | 136 | 76.7% | 77.6% | 6.4% |
| PHARM 320 | Year 2 | 2025-2026 | 134 | 74.6% | 76.1% | 8.6% |
| PHARM 320 | Year 2 | 2024-2025 | 133 | 76.3% | 77.3% | 7.7% |
| PHARM 320 | Year 2 | 2023-2024 | 139 | 75.8% | 76.7% | 7.5% |
| PHARM 323 | Year 2 | 2025-2026 | 133 | 73.6% | 74.3% | 7.9% |
| PHARM 323 | Year 2 | 2024-2025 | 133 | 74.2% | 74.7% | 8.2% |
| PHARM 323 | Year 2 | 2023-2024 | 139 | 75.5% | 77.1% | 8.5% |
| PHARM 420 | Year 3 | 2025-2026 | 130 | 77.8% | 78.2% | 7.1% |
| PHARM 420 | Year 3 | 2024-2025 | 135 | 82.2% | 83.2% | 7.1% |
| PHARM 420 | Year 3 | 2023-2024 | 125 | 74.9% | 74.3% | 7.9% |
| PHARM 423 | Year 3 | 2025-2026 | 130 | 76.3% | 76.5% | 8.4% |
| PHARM 423 | Year 3 | 2024-2025 | 133 | 73.9% | 74.9% | 6.8% |
| PHARM 423 | Year 3 | 2023-2024 | 126 | 75.8% | 76.1% | 5.3% |
Calculation note. For each student, exam scores were averaged within each course. Those course averages were then averaged to summarize performance across the stream. Years 1, 2 and 3 are shown separately.
How prepared do graduating students say they are, and where do they believe knowledge and skills were developed?
Graduating students rated how prepared they felt across the statements that make up each professional role. Within each role, read down from the most recent academic year to see how the response distribution has changed over time.
| AFPC professional role | Academic year | Overall graduating-student rating |
|---|---|---|
| Care Provider | 2025–26 | |
| 2024–25 | ||
| 2023–24 | ||
| Collaborator | 2025–26 | |
| 2024–25 | ||
| 2023–24 | ||
| Communicator | 2025–26 | |
| 2024–25 | ||
| 2023–24 |
Each row pools the six-point ratings across the governed statements contributing to that professional role. Point to or focus a bar for the median and share rated Prepared or Very prepared.
The eight lowest-rated stream-relevant topics in the most recent graduating-student survey are shown as full response distributions. The mean is used only to determine which topics appear.
| Topic | Graduating-student rating |
|---|---|
| practical compounding | |
| physical assessment | |
| virtual care provision | |
| diagnostic and point-of-care testing | |
| critical appraisal of medical literature | |
| evidence-based decision making | |
| care plan implementation | |
| drug information provision |
| accessing patient health information | 2025 | 5 | 87.3 |
| accessing patient health information | 2024 | 5 | 85.9 |
| administration of drugs by injection | 2026 | 5 | 93.8 |
| best possible medication history and medication reconciliation | 2026 | 5.5 | 93.8 |
| care plan development | 2026 | 5 | 91.2 |
| care plan implementation | 2026 | 5 | 83.8 |
| collaborative care and shared decision-making | 2026 | 5 | 85 |
| collection of patient data | 2026 | 6 | 97.5 |
| compounding | 2025 | 3 | 15.2 |
| compounding | 2024 | 3 | 16.3 |
| critical appraisal of medical literature | 2026 | 5 | 66.2 |
| diagnostic and point-of-care testing | 2026 | 5 | 66.2 |
| diagnostic testing (i.e. ordering and interpreting) | 2025 | 5 | 57.7 |
| diagnostic testing (i.e. ordering and interpreting) | 2024 | 5 | 50.5 |
| dispensing and prescription processing | 2026 | 5 | 86.2 |
| dispensing and prescription processing | 2025 | 5 | 82.3 |
| dispensing and prescription processing | 2024 | 5 | 73.7 |
| documentation of care | 2026 | 5 | 88.8 |
| documentation of care | 2025 | 5 | 88.6 |
| documentation of care | 2024 | 5 | 80.6 |
| drug information | 2025 | 5 | 77.2 |
| drug information | 2024 | 5 | 70.7 |
| drug information provision | 2026 | 5 | 85 |
| emergency first care | 2025 | 4 | 32 |
| emergency first care | 2024 | 4 | 28.1 |
| evidence-based decision making | 2026 | 5 | 78.8 |
| evidence-based decision making | 2025 | 5 | 68.4 |
| evidence-based decision making | 2024 | 5 | 59.6 |
| health promotion and disease prevention | 2025 | 5 | 73.1 |
| health promotion and disease prevention | 2024 | 5 | 61.6 |
| immunization and administration of drugs by injection | 2025 | 5 | 87.3 |
| immunization and administration of drugs by injection | 2024 | 5 | 85.9 |
| information technology and practice support tools | 2025 | 5 | 55.8 |
| information technology and practice support tools | 2024 | 5 | 54.6 |
| literature evaluation | 2025 | 5 | 55.7 |
| literature evaluation | 2024 | 4 | 49.5 |
| medication and patient safety practices | 2025 | 5 | 78.2 |
| medication and patient safety practices | 2024 | 5 | 71.4 |
| medication therapy management | 2025 | 5 | 85.9 |
| medication therapy management | 2024 | 5 | 74.7 |
| monitoring & follow-up | 2026 | 5 | 88.8 |
| outcomes monitoring | 2025 | 5 | 83.3 |
| outcomes monitoring | 2024 | 5 | 80.8 |
| patient and professional communications | 2026 | 5 | 90 |
| patient assessment | 2025 | 5 | 87.3 |
| patient assessment | 2024 | 5 | 83.8 |
| patient assessment/pharmacotherapy work-up | 2026 | 5 | 91.2 |
| patient education | 2025 | 5 | 89.9 |
| patient education | 2024 | 5 | 78.8 |
| patient safety | 2026 | 5 | 92.5 |
| pharmacist patient care process | 2026 | 5 | 96.2 |
| physical assessment | 2026 | 4 | 32.1 |
| physical assessment | 2025 | 4 | 35.9 |
| physical assessment | 2024 | 4 | 25.8 |
| point-of-care testing (i.e. conducting and interpreting) | 2025 | 5 | 55.1 |
| point-of-care testing (i.e. conducting and interpreting) | 2024 | 5 | 50.5 |
| practical compounding | 2026 | 4 | 33.8 |
| prescriptive decision making (i.e. prescribing, deprescribing, adapting a prescription) | 2026 | 5 | 87.5 |
| prescriptive decision making (i.e. prescribing, deprescribing, adapting a prescription) | 2025 | 5 | 81 |
| prescriptive decision making (i.e. prescribing, deprescribing, adapting a prescription) | 2024 | 5 | 71.7 |
| shared decision-making | 2025 | 5 | 84.8 |
| shared decision-making | 2024 | 5 | 73.7 |
| virtual care provision | 2026 | 4 | 41.8 |
These are graduating-student self-reports. They describe perceived preparedness and development, not demonstrated competence.
Graduating students rated how prepared they felt across the statements that make up each professional role. Within each role, read down from the most recent academic year to see how the response distribution has changed over time.
| AFPC professional role | Academic year | Overall graduating-student rating |
|---|---|---|
| Care Provider | 2025–26 | |
| 2024–25 | ||
| 2023–24 | ||
| Collaborator | 2025–26 | |
| 2024–25 | ||
| 2023–24 | ||
| Communicator | 2025–26 | |
| 2024–25 | ||
| 2023–24 |
Each row pools the six-point ratings across the governed statements contributing to that professional role. Point to or focus a bar for the median and share rated Prepared or Very prepared.
The eight lowest-rated stream-relevant topics in the most recent graduating-student survey are shown as full response distributions. The mean is used only to determine which topics appear.
| Topic | Graduating-student rating |
|---|---|
| practical compounding | |
| physical assessment | |
| virtual care provision | |
| diagnostic and point-of-care testing | |
| critical appraisal of medical literature | |
| evidence-based decision making | |
| care plan implementation | |
| drug information provision |
| accessing patient health information | 2025 | 5 | 87.3 |
| accessing patient health information | 2024 | 5 | 85.9 |
| administration of drugs by injection | 2026 | 5 | 93.8 |
| best possible medication history and medication reconciliation | 2026 | 5.5 | 93.8 |
| care plan development | 2026 | 5 | 91.2 |
| care plan implementation | 2026 | 5 | 83.8 |
| collaborative care and shared decision-making | 2026 | 5 | 85 |
| collection of patient data | 2026 | 6 | 97.5 |
| compounding | 2025 | 3 | 15.2 |
| compounding | 2024 | 3 | 16.3 |
| critical appraisal of medical literature | 2026 | 5 | 66.2 |
| diagnostic and point-of-care testing | 2026 | 5 | 66.2 |
| diagnostic testing (i.e. ordering and interpreting) | 2025 | 5 | 57.7 |
| diagnostic testing (i.e. ordering and interpreting) | 2024 | 5 | 50.5 |
| dispensing and prescription processing | 2026 | 5 | 86.2 |
| dispensing and prescription processing | 2025 | 5 | 82.3 |
| dispensing and prescription processing | 2024 | 5 | 73.7 |
| documentation of care | 2026 | 5 | 88.8 |
| documentation of care | 2025 | 5 | 88.6 |
| documentation of care | 2024 | 5 | 80.6 |
| drug information | 2025 | 5 | 77.2 |
| drug information | 2024 | 5 | 70.7 |
| drug information provision | 2026 | 5 | 85 |
| emergency first care | 2025 | 4 | 32 |
| emergency first care | 2024 | 4 | 28.1 |
| evidence-based decision making | 2026 | 5 | 78.8 |
| evidence-based decision making | 2025 | 5 | 68.4 |
| evidence-based decision making | 2024 | 5 | 59.6 |
| health promotion and disease prevention | 2025 | 5 | 73.1 |
| health promotion and disease prevention | 2024 | 5 | 61.6 |
| immunization and administration of drugs by injection | 2025 | 5 | 87.3 |
| immunization and administration of drugs by injection | 2024 | 5 | 85.9 |
| information technology and practice support tools | 2025 | 5 | 55.8 |
| information technology and practice support tools | 2024 | 5 | 54.6 |
| literature evaluation | 2025 | 5 | 55.7 |
| literature evaluation | 2024 | 4 | 49.5 |
| medication and patient safety practices | 2025 | 5 | 78.2 |
| medication and patient safety practices | 2024 | 5 | 71.4 |
| medication therapy management | 2025 | 5 | 85.9 |
| medication therapy management | 2024 | 5 | 74.7 |
| monitoring & follow-up | 2026 | 5 | 88.8 |
| outcomes monitoring | 2025 | 5 | 83.3 |
| outcomes monitoring | 2024 | 5 | 80.8 |
| patient and professional communications | 2026 | 5 | 90 |
| patient assessment | 2025 | 5 | 87.3 |
| patient assessment | 2024 | 5 | 83.8 |
| patient assessment/pharmacotherapy work-up | 2026 | 5 | 91.2 |
| patient education | 2025 | 5 | 89.9 |
| patient education | 2024 | 5 | 78.8 |
| patient safety | 2026 | 5 | 92.5 |
| pharmacist patient care process | 2026 | 5 | 96.2 |
| physical assessment | 2026 | 4 | 32.1 |
| physical assessment | 2025 | 4 | 35.9 |
| physical assessment | 2024 | 4 | 25.8 |
| point-of-care testing (i.e. conducting and interpreting) | 2025 | 5 | 55.1 |
| point-of-care testing (i.e. conducting and interpreting) | 2024 | 5 | 50.5 |
| practical compounding | 2026 | 4 | 33.8 |
| prescriptive decision making (i.e. prescribing, deprescribing, adapting a prescription) | 2026 | 5 | 87.5 |
| prescriptive decision making (i.e. prescribing, deprescribing, adapting a prescription) | 2025 | 5 | 81 |
| prescriptive decision making (i.e. prescribing, deprescribing, adapting a prescription) | 2024 | 5 | 71.7 |
| shared decision-making | 2025 | 5 | 84.8 |
| shared decision-making | 2024 | 5 | 73.7 |
| virtual care provision | 2026 | 4 | 41.8 |
These are graduating-student self-reports. They describe perceived preparedness and development, not demonstrated competence.
Graduating students rated how prepared they felt across the statements that make up each professional role. Within each role, read down from the most recent academic year to see how the response distribution has changed over time.
| AFPC professional role | Academic year | Overall graduating-student rating |
|---|---|---|
| Care Provider | 2025–26 | |
| 2024–25 | ||
| 2023–24 | ||
| Collaborator | 2025–26 | |
| 2024–25 | ||
| 2023–24 | ||
| Communicator | 2025–26 | |
| 2024–25 | ||
| 2023–24 |
Each row pools the six-point ratings across the governed statements contributing to that professional role. Point to or focus a bar for the median and share rated Prepared or Very prepared.
The eight lowest-rated stream-relevant topics in the most recent graduating-student survey are shown as full response distributions. The mean is used only to determine which topics appear.
| Topic | Graduating-student rating |
|---|---|
| practical compounding | |
| physical assessment | |
| virtual care provision | |
| diagnostic and point-of-care testing | |
| critical appraisal of medical literature | |
| evidence-based decision making | |
| care plan implementation | |
| drug information provision |
| accessing patient health information | 2025 | 5 | 87.3 |
| accessing patient health information | 2024 | 5 | 85.9 |
| administration of drugs by injection | 2026 | 5 | 93.8 |
| best possible medication history and medication reconciliation | 2026 | 5.5 | 93.8 |
| care plan development | 2026 | 5 | 91.2 |
| care plan implementation | 2026 | 5 | 83.8 |
| collaborative care and shared decision-making | 2026 | 5 | 85 |
| collection of patient data | 2026 | 6 | 97.5 |
| compounding | 2025 | 3 | 15.2 |
| compounding | 2024 | 3 | 16.3 |
| critical appraisal of medical literature | 2026 | 5 | 66.2 |
| diagnostic and point-of-care testing | 2026 | 5 | 66.2 |
| diagnostic testing (i.e. ordering and interpreting) | 2025 | 5 | 57.7 |
| diagnostic testing (i.e. ordering and interpreting) | 2024 | 5 | 50.5 |
| dispensing and prescription processing | 2026 | 5 | 86.2 |
| dispensing and prescription processing | 2025 | 5 | 82.3 |
| dispensing and prescription processing | 2024 | 5 | 73.7 |
| documentation of care | 2026 | 5 | 88.8 |
| documentation of care | 2025 | 5 | 88.6 |
| documentation of care | 2024 | 5 | 80.6 |
| drug information | 2025 | 5 | 77.2 |
| drug information | 2024 | 5 | 70.7 |
| drug information provision | 2026 | 5 | 85 |
| emergency first care | 2025 | 4 | 32 |
| emergency first care | 2024 | 4 | 28.1 |
| evidence-based decision making | 2026 | 5 | 78.8 |
| evidence-based decision making | 2025 | 5 | 68.4 |
| evidence-based decision making | 2024 | 5 | 59.6 |
| health promotion and disease prevention | 2025 | 5 | 73.1 |
| health promotion and disease prevention | 2024 | 5 | 61.6 |
| immunization and administration of drugs by injection | 2025 | 5 | 87.3 |
| immunization and administration of drugs by injection | 2024 | 5 | 85.9 |
| information technology and practice support tools | 2025 | 5 | 55.8 |
| information technology and practice support tools | 2024 | 5 | 54.6 |
| literature evaluation | 2025 | 5 | 55.7 |
| literature evaluation | 2024 | 4 | 49.5 |
| medication and patient safety practices | 2025 | 5 | 78.2 |
| medication and patient safety practices | 2024 | 5 | 71.4 |
| medication therapy management | 2025 | 5 | 85.9 |
| medication therapy management | 2024 | 5 | 74.7 |
| monitoring & follow-up | 2026 | 5 | 88.8 |
| outcomes monitoring | 2025 | 5 | 83.3 |
| outcomes monitoring | 2024 | 5 | 80.8 |
| patient and professional communications | 2026 | 5 | 90 |
| patient assessment | 2025 | 5 | 87.3 |
| patient assessment | 2024 | 5 | 83.8 |
| patient assessment/pharmacotherapy work-up | 2026 | 5 | 91.2 |
| patient education | 2025 | 5 | 89.9 |
| patient education | 2024 | 5 | 78.8 |
| patient safety | 2026 | 5 | 92.5 |
| pharmacist patient care process | 2026 | 5 | 96.2 |
| physical assessment | 2026 | 4 | 32.1 |
| physical assessment | 2025 | 4 | 35.9 |
| physical assessment | 2024 | 4 | 25.8 |
| point-of-care testing (i.e. conducting and interpreting) | 2025 | 5 | 55.1 |
| point-of-care testing (i.e. conducting and interpreting) | 2024 | 5 | 50.5 |
| practical compounding | 2026 | 4 | 33.8 |
| prescriptive decision making (i.e. prescribing, deprescribing, adapting a prescription) | 2026 | 5 | 87.5 |
| prescriptive decision making (i.e. prescribing, deprescribing, adapting a prescription) | 2025 | 5 | 81 |
| prescriptive decision making (i.e. prescribing, deprescribing, adapting a prescription) | 2024 | 5 | 71.7 |
| shared decision-making | 2025 | 5 | 84.8 |
| shared decision-making | 2024 | 5 | 73.7 |
| virtual care provision | 2026 | 4 | 41.8 |
These are graduating-student self-reports. They describe perceived preparedness and development, not demonstrated competence.
What does PEBC evidence add to the picture of achievement?
Within each area, read from the most recent reporting year to earlier reporting years. MCQ average item-difficulty scale. Lower values indicate stronger relative performance on this PEBC measure. National values are shown only where they are already available in the governed PEBC evidence. To keep the stream view focused, the figure shows the highest-relevance competencies identified by the governed PEBC-to-AFPC-to-stream crosswalk.
Within each area, read from the most recent reporting year to earlier reporting years. OSCE competency-rating scale shown on the axis. National values are shown only where they are already available in the governed PEBC evidence. To keep the stream view focused, the figure shows the highest-relevance competencies identified by the governed PEBC-to-AFPC-to-stream crosswalk.
Within each area, read from the most recent reporting year to earlier reporting years. 1–4 OSCE global-rating scale. Higher values indicate stronger ratings. National values are shown only where they are already available in the governed PEBC evidence.
MCQ and OSCE retain their own original measures and scales. Stream relationships establish relevance, not causal attribution.
Within each area, read from the most recent reporting year to earlier reporting years. MCQ average item-difficulty scale. Lower values indicate stronger relative performance on this PEBC measure. National values are shown only where they are already available in the governed PEBC evidence. To keep the stream view focused, the figure shows the highest-relevance competencies identified by the governed PEBC-to-AFPC-to-stream crosswalk.
Within each area, read from the most recent reporting year to earlier reporting years. OSCE competency-rating scale shown on the axis. National values are shown only where they are already available in the governed PEBC evidence. To keep the stream view focused, the figure shows the highest-relevance competencies identified by the governed PEBC-to-AFPC-to-stream crosswalk.
Within each area, read from the most recent reporting year to earlier reporting years. 1–4 OSCE global-rating scale. Higher values indicate stronger ratings. National values are shown only where they are already available in the governed PEBC evidence.
MCQ and OSCE retain their own original measures and scales. Stream relationships establish relevance, not causal attribution.
Within each area, read from the most recent reporting year to earlier reporting years. MCQ average item-difficulty scale. Lower values indicate stronger relative performance on this PEBC measure. National values are shown only where they are already available in the governed PEBC evidence. To keep the stream view focused, the figure shows the highest-relevance competencies identified by the governed PEBC-to-AFPC-to-stream crosswalk.
Within each area, read from the most recent reporting year to earlier reporting years. OSCE competency-rating scale shown on the axis. National values are shown only where they are already available in the governed PEBC evidence. To keep the stream view focused, the figure shows the highest-relevance competencies identified by the governed PEBC-to-AFPC-to-stream crosswalk.
Within each area, read from the most recent reporting year to earlier reporting years. 1–4 OSCE global-rating scale. Higher values indicate stronger ratings. National values are shown only where they are already available in the governed PEBC evidence.
MCQ and OSCE retain their own original measures and scales. Stream relationships establish relevance, not causal attribution.
What becomes clearer when these perspectives are considered together?
Putting these perspectives side‑by‑side makes clearer where different lenses point to strengths: on the most recent graduating‑student survey learners rate themselves highly as care providers, collaborators and communicators; OSCE competency results in 2025 sit above national benchmarks for patient care, knowledge application and inter‑professional collaboration, while MCQ competency metrics in 2025 are generally a bit less favorable than national benchmarks in areas like product distribution, health promotion and quality/safety. The program performance snapshot shows first‑year practical performance notably higher than years two and three, with small declines reported in later years.
What still needs to be kept separate or interpreted cautiously: these sources use different measures, reporting periods and scales (self‑report vs MCQ vs OSCE vs internal practical metrics), so their numbers should not be pooled or directly equated; MCQ and OSCE scores are on different scales and should be read independently. PEBC results are from 2025 only, AFPC items are from the most recent survey year, and assessment‑quality detail is unavailable, so trends over time and causal conclusions are not supported.
Putting these perspectives side‑by‑side makes clearer where different lenses point to strengths: on the most recent graduating‑student survey learners rate themselves highly as care providers, collaborators and communicators; OSCE competency results in 2025 sit above national benchmarks for patient care, knowledge application and inter‑professional collaboration, while MCQ competency metrics in 2025 are generally a bit less favorable than national benchmarks in areas like product distribution, health promotion and quality/safety. The program performance snapshot shows first‑year practical performance notably higher than years two and three, with small declines reported in later years.
What still needs to be kept separate or interpreted cautiously: these sources use different measures, reporting periods and scales (self‑report vs MCQ vs OSCE vs internal practical metrics), so their numbers should not be pooled or directly equated; MCQ and OSCE scores are on different scales and should be read independently. PEBC results are from 2025 only, AFPC items are from the most recent survey year, and assessment‑quality detail is unavailable, so trends over time and causal conclusions are not supported.
Putting these perspectives side‑by‑side makes clearer where different lenses point to strengths: on the most recent graduating‑student survey learners rate themselves highly as care providers, collaborators and communicators; OSCE competency results in 2025 sit above national benchmarks for patient care, knowledge application and inter‑professional collaboration, while MCQ competency metrics in 2025 are generally a bit less favorable than national benchmarks in areas like product distribution, health promotion and quality/safety. The program performance snapshot shows first‑year practical performance notably higher than years two and three, with small declines reported in later years.
What still needs to be kept separate or interpreted cautiously: these sources use different measures, reporting periods and scales (self‑report vs MCQ vs OSCE vs internal practical metrics), so their numbers should not be pooled or directly equated; MCQ and OSCE scores are on different scales and should be read independently. PEBC results are from 2025 only, AFPC items are from the most recent survey year, and assessment‑quality detail is unavailable, so trends over time and causal conclusions are not supported.
What questions does the achievement evidence warrant further consideration?
Where did this information come from, and how was it prepared?
This workspace brings together several different perspectives on achievement for the selected pharmacy stream: performance in program assessments, information about how written exams are functioning, graduating-student self-report, and PEBC licensure results.
These sources answer different questions and are kept separate. Program assessments show performance within the curriculum, graduating-student surveys describe perceived preparedness and development, and PEBC provides an external perspective after the program.
Program-performance figures summarize student exam performance within each course and then across courses in the stream. Program years are shown separately, and the most recent academic year can be compared with earlier academic years using the same calculation.
Assessment-quality figures provide additional context about how individual written exams and exam questions are functioning. Exam reliability and item statistics can help identify results that deserve closer review, but they do not establish whether an exam adequately covers the intended curriculum.
Exam reliability describes an individual assessment, not the reliability of a final course grade that combines several assessments.
AFPC professional-role preparedness and CCAPP knowledge-and-skill development use six-point response scales. The coloured bars show the full distribution of student responses rather than reducing the result to a single score. Hover or keyboard focus provides the median and the share of responses in the two most favourable categories.
The professional-role figure compares the same role across available survey years. The knowledge-and-skill figure shows the eight lowest-rated stream-relevant topics in the most recent survey; the mean is used only to select those topics, while the displayed evidence remains the full response distribution.
These are student self-reports. They complement demonstrated achievement evidence but are not treated as direct measures of competence.
PEBC results are displayed on their original assessment-specific scales. MCQ competency results, OSCE competency results, and the available 1–4 OSCE global ratings are shown separately. Within each figure, the most recent reporting year appears first so changes can be followed over time.
UAlberta results are shown alongside the national value when that comparison already exists in the governed PEBC evidence. Missing national values are left absent rather than reconstructed.
PEBC reporting years are not treated as equivalent to the academic-cycle selector, and relationships to a stream establish relevance rather than showing that the stream caused the result.
The report first prepares the quantitative evidence and its source-specific limits. AI-assisted writing is then used to create concise educator-facing What stands out notes, cross-evidence orientation, and review questions from those prepared records.
AI-assisted writing does not calculate the figures, combine unlike scales, decide whether learning outcomes have been achieved, determine why a pattern occurred, or recommend curriculum changes. Those judgments remain with the educators reviewing the evidence.
The written summaries are prepared before the report is displayed. Opening or browsing this report does not send a new request to an AI service.
A visible difference between academic years, survey years, or PEBC reporting years does not by itself establish an educationally important improvement or decline. Each source should first be interpreted on its own scale and within its own reporting period.
When evidence is missing, not comparable, unavailable for a stream, or reported on a different scale, the workspace keeps that limitation visible rather than filling the gap or creating a combined achievement score.